(Q35769514)

English

Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours

scientific article published on January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor kappaB ligand (RANKL) in human breast tumours (English)

1 reference

Europe PubMed Central

10 August 2017

2

1 reference

Europe PubMed Central

10 August 2017

object named as

I Holen

8

0 references

object named as

L Norton

6

0 references

Katherine S Panageas

5

object named as

K S Panageas

1 reference

Europe PubMed Central

10 August 2017

author name string

C Van Poznak

1

1 reference

Europe PubMed Central

10 August 2017

M Saggese

3

1 reference

Europe PubMed Central

10 August 2017

C Hudis

4

1 reference

Europe PubMed Central

10 August 2017

R E Coleman

7

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

1 January 2006

1 reference

Europe PubMed Central

10 August 2017

Journal of Clinical Pathology

1 reference

Europe PubMed Central

10 August 2017

59

1 reference

Europe PubMed Central

10 August 2017

1

1 reference

Europe PubMed Central

10 August 2017

56-63

1 reference

Europe PubMed Central

10 August 2017

Anticancer therapy targeting the apoptotic pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Receptor activator of nuclear factor kappaB ligand (RANKL)/osteoprotegerin (OPG) ratio is increased in severe osteolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

The diagnosis and management of pre-invasive breast disease: flat epithelial atypia--classification, pathologic features and clinical significance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Columnar Cell Lesions of the Breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Osteoprotegerin (OPG) is a survival factor for human prostate cancer cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Osteoprotegerin and rank ligand expression in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Osteoprotegerin, a crucial regulator of bone metabolism, also regulates B cell development and function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

The receptor for the cytotoxic ligand TRAIL

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

The clinical course of bone metastases from breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

27 July 2018

Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

25 September 2018

Expression of osteoprotegerin correlates with aggressiveness and poor prognosis of gastric carcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

25 September 2018

Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

25 September 2018

Tumour cells produce receptor activator of NF-kappaB ligand (RANKL) in skeletal metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

25 September 2018

Metastasis to bone: causes, consequences and therapeutic opportunities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

25 September 2018

Receptor activator of nuclear factor kappa B ligand (RANKL): another link between breast and bone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860269

25 September 2018

Osteoprotegerin (OPG) produced by bone marrow stromal cells protects breast cancer cells from TRAIL-induced apoptosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16394281

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical study of receptor activator of nuclear factor kappa-B ligand (RANK-L) in human osteolytic bone tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16394281

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum osteoprotegerin levels in healthy controls and cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16394281

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR

1 reference

https://pubmed.ncbi.nlm.nih.gov/16394281

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of the apoptosis-inducing ligands FasL and TRAIL in malignant and benign human breast tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16394281

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16394281

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of in situ carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/16394281

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Columnar alteration with prominent apical snouts and secretions: a spectrum of changes frequently present in breast biopsies performed for microcalcifications

1 reference

https://pubmed.ncbi.nlm.nih.gov/16394281

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer cells interact with osteoblasts to support osteoclast formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16394281

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JCP.2005.026534

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35769514&oldid=2009805900"